Gut microbial biomarkers for the treatment response in first-episode, drug-naïve schizophrenia: a 24-week follow-up study

Preclinical studies have shown that the gut microbiota can play a role in schizophrenia (SCH) pathogenesis via the gut-brain axis. However, its role in the antipsychotic treatment response is unclear. Here, we present a 24-week follow-up study to identify gut microbial biomarkers for SCH diagnosis a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Xiuxia, Wang, Yunpeng, Li, Xue, Jiang, Jiajun, Kang, Yulin, Pang, Lijuan, Zhang, Peifen, Li, Ang, Lv, Luxian, Andreassen, Ole A., Fan, Xiaoduo, Hu, Shaohua, Song, Xueqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355081/
https://www.ncbi.nlm.nih.gov/pubmed/34376634
http://dx.doi.org/10.1038/s41398-021-01531-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355081/
https://www.ncbi.nlm.nih.gov/pubmed/34376634
http://dx.doi.org/10.1038/s41398-021-01531-3

Ejemplares similares